Background & Aims
Chronic neuropathic pain (NeP) is a debilitating condition that reduces quality of life 1-4. Underlying mechanisms are not well understood, but astrocytes and microglia are known to play central roles 5,6. When activated, they undergo not only morphological-, but also transcriptional changes 7-10. This may promote a shift in functions that can have both protective and detrimental effects on the surrounding neuroparenchyma 9. Like humans, dogs of the Cavalier King Charles Spaniel (CKCS) breed suffer from syringomyelia (SM) with NeP 11-12. We study pain pathophysiology in spinal cords from CKCS with SM and NeP that are euthanized due to unacceptable quality of life. We have previously reported degenerative changes affecting spinal cord nociceptive pathways 13,14. By examining transcriptomic changes in astrocytes and microglia in spinal cord tissue of affected CKCSs, we aim to identify cellular and molecular mechanisms that contribute to the development and maintenance of NeP.
Methods
Spinal cord tissue from 18 privately owned CKCSs with and without SM: 13 cases from the neurology clinic at Copenhagen University Hospital for Companion Animals, Denmark and five from University of Surrey and University of Cambridge, United Kingdom. Dogs were euthanized due to uncontrollable SM-related pain or non-neurological disease and donated by their owners for postmortem research. NanoString’s Geomx technology and their canine-specific panel were used to explore gene regulations in astrocytes and microglia and to investigate the genes’ potential roles in NeP. To identify astrocytes and microglia, all samples were preliminarily stained with rabbit Alexa Fluor 594-conjugate anti–glial fibrillary acidic protein (GFAP) monoclonal antibody, unconjugated rabbit anti-ionized calcium-binding adaptor molecule 1 (IBA1) polyclonal antibody, Alexa Flour 647-conjugate goat anti-rabbit and polyclonal anti-rabbit immunoglobulin G.
Results
Dogs were classified as: symptomatic and asymptomatic presyrinx (n=1+1), symptomatic and asymptomatic SM (n=11+2) and controls (n=3). The most predominant clinical signs of NeP were vocalization, hypersensitivity to touch, scratching of the neck and shoulder, aggravation of scratching by emotional arousal, and neck pain. Presyrinx was defined as a central canal <2 mm and dorsal horn gray matter edema. SM was defined as a central canal >2 mm with edema and loss of structure to the dorsal horn.
Preliminary results from immunofluorescence staining with GFAP (astrocytic marker) showed increased intensity in the majority of dogs with symptomatic syringomyelia and symptomatic presyrinx, compared to controls.
Conclusions
The final results of the spatial transcriptomic analysis as well as conclusions will be presented at the poster session.
References
[1]Rusbridge C, Mcfadyen AK, Knower SP. Behavioral and clinical signs of Chiari-like malformation-associated pain and syringomyelia in Cavalier King Charles spaniels. Journal of Veterinary Internal Medicine 2019;33:2138–2150.
[2]Ruel HLM, Watanabe R, Evangelista MC, Beauchamp G, Auger JP, Segura M, Steagall P V. Pain burden, sensory profile and inflammatory cytokines of dogs with naturally-occurring neuropathic pain treated with gabapentin alone or with meloxicam. PLoS ONE 2020;15:1–19.
[3]Finnerup NB, Kuner R, Jensen TS. Neuropathic pain: From Mechanisms to Treatment. Physiol Rev 2021;101:259–301.
[4]Monteiro BP, Lascelles BDX, Murrell J, Robertson S, Steagall PVM, Wright B. 2022 WSAVA guidelines for the recognition, assessment and treatment of pain. Journal of Small Animal Practice 2022;64:177–254.
[5]Chen G, Zhang YQ, Qadri YJ, Serhan CN, Ji RR. Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain. Neuron 2018;100:1292–1311.
[6]Fan YY, Huo J. A1/A2 astrocytes in central nervous system injuries and diseases: Angels or devils? Neurochemistry International 2021;148:105080.
[7]Liddelow SA, Marsh SE, Stevens B. Microglia and Astrocytes in Disease: Dynamic Duo or Partners in Crime? Trends in Immunology 2020;41:820–835.
[8]Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, Münch AE, Chung WS, Peterson TC, Wilton DK, Frouin A, Napier BA, Panicker N, Kumar M, Buckwalter MS, Rowitch DH, Dawson VL, Dawson TM, Stevens B, Barres BA. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 2017;541:481–487.
[9]Escartin C, Galea E, Lakatos A, O’Callaghan JP, Petzold GC, Serrano-Pozo A, Steinhäuser C, Volterra A, Carmignoto G, Agarwal A, Allen NJ, Araque A, Barbeito L, Barzilai A, Bergles DE, Bonvento G, Butt AM, Chen WT, Cohen-Salmon M, Cunningham C, Deneen B, De Strooper B, Díaz-Castro B, Farina C, Freeman M, Gallo V, Goldman JE, Goldman SA, Götz M, Gutiérrez A, Haydon PG, Heiland DH, Hol EM, Holt MG, Iino M, Kastanenka K V., Kettenmann H, Khakh BS, Koizumi S, Lee CJ, Liddelow SA, MacVicar BA, Magistretti P, Messing A, Mishra A, Molofsky A V., Murai KK, Norris CM, Okada S, Oliet SHR, Oliveira JF, Panatier A, Parpura V, Pekna M, Pekny M, Pellerin L, Perea G, Pérez-Nievas BG, Pfrieger FW, Poskanzer KE, Quintana FJ, Ransohoff RM, Riquelme-Perez M, Robel S, Rose CR, Rothstein JD, Rouach N, Rowitch DH, Semyanov A, Sirko S, Sontheimer H, Swanson RA, Vitorica J, Wanner IB, Wood LB, Wu J, Zheng B, Zimmer ER, Zorec R, Sofroniew M V., Verkhratsky A. Reactive astrocyte nomenclature, definitions, and future directions. Nature Neuroscience 2021;24:312–325.
[10]Chen O, Luo X, Ji RR. Macrophages and microglia in inflammation and neuroinflammation underlying different pain states. Medical Review 2023;3:381–407.
[11]Thøfner MS, Stougaard CL, Westrup U, Madry AA, Knudsen CS, Berg H, Jensen CSE, Handby RML, Gredal H, Fredholm M, Berendt M. Prevalence and Heritability of Symptomatic Syringomyelia in Cavalier King Charles Spaniels and Long-term Outcome in Symptomatic and Asymptomatic Littermates. J Vet Intern Med 2015;29:243–250.
[12]Pedersen TR, Bach MBT, Stougaard CL, Gredal H, Rusbridge C, Finnerup NB, Berendt M. Clinical predictors of syringomyelia in Cavalier King Charles Spaniels with chiari-like malformation based on owners’ observations. Acta Vet Scand 2024;66:1-9.
[13]Hu HZ, Rusbridge C, Constantino-Casas F, Jeffery N. Histopathological Investigation of Syringomyelia in the Cavalier King Charles Spaniel. Journal of Comparative Pathology 2012;146:192–201.
[14]Mortensen D, Thoefner MS, Agerholm JS, Slumstrup L, Jensen TS, Bjerrum OJ, Berendt M, Nyengaard JR. Dorsal horn volume loss and pain pathway changes in Cavalier King Charles Spaniels with syringomyelia, signs of pain, and phantom scratching. Pain 2022;163:2365–2379.
Presenting Author
Tenna Pedersen
Poster Authors
Tenna Pedersen
DVM
Department of Veterinary Clinical Sciences, University of Copenhagen
Lead Author
Jørgen Steen Agerholm
DVM
Department of Veterinary Clinical Sciences, University of Copenhagen
Lead Author
Clare Rusbridge
BVMS
Department of Clinical Sciences, School of Veterinary Medicine, University of Surrey,
Lead Author
Fernando Constantino Casas
MVZ
Department of Veterinary Medicine, University of Cambridge
Lead Author
Nanna Finnerup
The Danish Pain Research Center - Department of Clinical Medicine, Aarhus University
Lead Author
Mette Berendt
DVM
Department of Veterinary Clinical Sciences, University of Copenhagen
Lead Author
Jens Randel Nyengaard
MD
Department of Clinical Medicine - Core Centre for Molecular Morphology, Aarhus University
Lead Author
Topics
- Pain in Special Populations: Non-verbal